We've found
184,457
clinical trials
Sickle Cell Disease Clinical Trial
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Refractory Multiple Myeloma Clinical Trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 4/9/2018
Click here to add this to my saved trials
Metastatic Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 1/20/2016
Click here to add this to my saved trials
Metastatic Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 1/20/2016
Click here to add this to my saved trials
Metastatic Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 1/20/2016
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Enhancing the Efficacy of Smoking Quit Line in the Military (AFIII Renewal)
Status: Enrolling,
Phase
III
Updated: 11/23/2015
Click here to add this to my saved trials
Other Clinical Trial
Non-Invasive Chromosomal Evaluation of Trisomy Study
Status: Enrolling
Updated: 8/12/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Mediastinal B-cell Lymphoma Clinical Trial
Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-small Cell Lung Cancer Stage IV Clinical Trial
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Enrolling,
Phase
II
Updated: 3/10/2016
Click here to add this to my saved trials
Non-small Cell Lung Cancer Stage IV Clinical Trial
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Enrolling,
Phase
II
Updated: 3/10/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Parents Who Have Lost a Child to Cancer Clinical Trial
Development of Psychotherapeutic Interventions for Parents Who Lost a Child to Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Other, Reproductive Clinical Trial
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling,
Phase
II
Updated: 2/18/2016
Click here to add this to my saved trials
Other, Reproductive Clinical Trial
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling,
Phase
II
Updated: 2/18/2016
Click here to add this to my saved trials
Other, Reproductive Clinical Trial
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling,
Phase
II
Updated: 2/18/2016
Click here to add this to my saved trials
Hematology Clinical Trial
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alcohol Abuse Clinical Trial
Motivational Incentives for Alcohol Abstinence in American Indian and Native Alaskan Adults
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Clinical Trial
LIFE Study: Least Invasive Fast-Track EVAR
Status: Enrolling
Updated: 11/24/2015
Click here to add this to my saved trials
Acute Oral Mucositis Pain Clinical Trial
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials
Acute Oral Mucositis Pain Clinical Trial
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials
Acute Oral Mucositis Pain Clinical Trial
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials
Acute Oral Mucositis Pain Clinical Trial
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials
Acute Oral Mucositis Pain Clinical Trial
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials
Acute Oral Mucositis Pain Clinical Trial
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials
We've found
184,457
clinical trials
Sickle Cell Disease Clinical Trial
Updated: 12/31/1969
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Refractory Multiple Myeloma Clinical Trial
Updated: 4/9/2018
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 4/9/2018
Click here to add this to my saved trials

Metastatic Small Cell Lung Cancer Clinical Trial
Updated: 1/20/2016
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 1/20/2016
Click here to add this to my saved trials

Metastatic Small Cell Lung Cancer Clinical Trial
Updated: 1/20/2016
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 1/20/2016
Click here to add this to my saved trials

Metastatic Small Cell Lung Cancer Clinical Trial
Updated: 1/20/2016
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 1/20/2016
Click here to add this to my saved trials

Epilepsy Clinical Trial
Updated: 12/31/1969
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Epilepsy Clinical Trial
Updated: 12/31/1969
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Epilepsy Clinical Trial
Updated: 12/31/1969
A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 11/23/2015
Enhancing the Efficacy of Smoking Quit Line in the Military (AFIII Renewal)
Status: Enrolling,
Phase
III
Updated: 11/23/2015
Click here to add this to my saved trials

Other Clinical Trial
Updated: 8/12/2015
Non-Invasive Chromosomal Evaluation of Trisomy Study
Status: Enrolling
Updated: 8/12/2015
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Mediastinal B-cell Lymphoma Clinical Trial
Updated: 12/31/1969
Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Solid Tumours Clinical Trial
Updated: 12/31/1969
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Non-small Cell Lung Cancer Stage IV Clinical Trial
Updated: 3/10/2016
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Enrolling,
Phase
II
Updated: 3/10/2016
Click here to add this to my saved trials

Non-small Cell Lung Cancer Stage IV Clinical Trial
Updated: 3/10/2016
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Enrolling,
Phase
II
Updated: 3/10/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/25/2016
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/25/2016
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/25/2016
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/25/2016
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/25/2016
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/25/2016
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials

Parents Who Have Lost a Child to Cancer Clinical Trial
Updated: 12/31/1969
Development of Psychotherapeutic Interventions for Parents Who Lost a Child to Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Other, Reproductive Clinical Trial
Updated: 2/18/2016
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling,
Phase
II
Updated: 2/18/2016
Click here to add this to my saved trials

Other, Reproductive Clinical Trial
Updated: 2/18/2016
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling,
Phase
II
Updated: 2/18/2016
Click here to add this to my saved trials

Other, Reproductive Clinical Trial
Updated: 2/18/2016
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
Status: Enrolling,
Phase
II
Updated: 2/18/2016
Click here to add this to my saved trials

Hematology Clinical Trial
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Alcohol Abuse Clinical Trial
Updated: 12/14/2017
Motivational Incentives for Alcohol Abstinence in American Indian and Native Alaskan Adults
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Malignant Melanoma Clinical Trial
Updated: 5/25/2016
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials

Neoplasms Clinical Trial
Updated: 12/31/1969
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasms Clinical Trial
Updated: 12/31/1969
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Abdominal Aortic Aneurysm Clinical Trial
Updated: 11/24/2015
LIFE Study: Least Invasive Fast-Track EVAR
Status: Enrolling
Updated: 11/24/2015
Click here to add this to my saved trials

Acute Oral Mucositis Pain Clinical Trial
Updated: 8/4/2015
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials

Acute Oral Mucositis Pain Clinical Trial
Updated: 8/4/2015
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials

Acute Oral Mucositis Pain Clinical Trial
Updated: 8/4/2015
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials

Acute Oral Mucositis Pain Clinical Trial
Updated: 8/4/2015
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials

Acute Oral Mucositis Pain Clinical Trial
Updated: 8/4/2015
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials

Acute Oral Mucositis Pain Clinical Trial
Updated: 8/4/2015
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials
